mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0024 |
0.9 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.0038 |
1 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
1 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
1 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
0.0087 |
1 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.0022 |
1 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0017 |
1 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.0018 |
1 |